
Commercial leaders in life sciences rarely get a second chance when they choose an outside partner. A firm usually comes in to support a launch, fix an execution problem, or move a commercial strategy forward. Those decisions come with tight timelines, limited budgets, and results that the leader who chose the firm will be judged on.
Many of those choices get made this time of year, as commercial teams set next year’s budgets and decide which firms will support their launches, POA meetings, and field initiatives. Most selection processes still put the most weight on credentials, references, and pricing. Those matter, but they don’t tell you whether a firm will act like a partner once the work gets hard.
Choosing a life sciences consulting partner depends on something simpler and harder to judge: whether the firm and your leadership team share the same commitment to candor and ownership. That starts with your own leaders.
Partnerships break down when leaders work harder at looking capable than at being honest about what’s happening. Commercial leadership rewards certainty and control, and there is little patience for saying “we don’t know,” “we’re stuck,” or “we’ve let this go on too long.” The natural reflex is to protect credibility, so leaders manage their language and present a cleaner version of reality than the one their teams live with.
Then they bring in a consultant and expect transformation. A firm can only respond to what it sees. When what it sees has been filtered, the work never goes deep enough to change results. Strong partners work on what is actually happening, and that is often different from what was presented at kickoff.
Partnerships rarely fall apart in one dramatic moment. They wear down slowly as leaders stay careful instead of candid. Leaders avoid naming internal misalignment, soften the language around performance issues, and protect individuals when a behavior is the real problem.
Eventually the leader feels let down and wonders why the firm isn’t delivering. When results stall, the diagnosis often lands in the wrong place. A partner can challenge your thinking and help you solve a problem, but it can’t make your organization admit what the problem really is.
Every organization has blind spots, including high-performing ones. Success creates habits, and the longer a team works together, the harder it becomes to see which of those habits no longer serve the work. In pharma commercial teams, certain behaviors get tolerated and inefficiencies get defended as “how we operate.” That is ordinary human behavior inside a complex organization.
This is why an outside perspective has value. No one can fully diagnose an organization they are part of, and no leader can objectively assess dynamics they helped create. Even experienced commercial leaders misjudge their own teams in predictable ways. The leaders who get the most from a consulting partner are the ones willing to hear what the partner sees and act on it.
A strong partnership takes work from both sides, and the payoff is a working relationship where nothing important goes unsaid. A real partner asks difficult questions early. It names risk instead of working around it, and it addresses misalignment directly instead of quietly compensating for it.
The difference between a vendor and a strategic partner shows up when pressure builds and outcomes stop being predictable. At that point, weak partnerships retreat into roles and contract scope, while strong ones move toward the problem with you. If a firm only collaborates well when things are going well, you’ve chosen a vendor with better messaging.

A partner can challenge your thinking and help you solve a problem, but it can’t make your organization admit what the problem really is.
No firm can make up for absent leadership. Many client and firm relationships fail because executive sponsorship fades, decisions stall, or internal alignment never happens. The firm gets blamed for the results, but the conditions for success were never in place.
Partners bring expertise, and leaders create the environment where that expertise turns into changed behavior in the field. When leadership disengages, the engagement continues but stops producing results.
Before you review another proposal, ask questions that predict how a firm will behave once the work starts:
Then ask the firm for evidence, such as how its clients rated the work at project close and what happened when an engagement went off track. An evaluation that stops at credentials will make the wrong firm look right.
The truth about a partnership is clearest at the end. Ask whether both sides left with clarity about what worked, whether there was candor when things got difficult, and whether lessons were actually applied or only written down. Not every partnership should last forever, and ending one is a normal outcome. A partnership that ends without honesty or ownership on either side was never fully built.
The value of a consulting partner is the confidence that someone will tell you the truth when it’s uncomfortable and name the blind spots your team can’t see. Firms are remembered for whether they stayed honest and accountable when it mattered, far more than for their frameworks or presentations.
So before choosing a life sciences consulting partner for next year, decide whether your own leadership team is ready to be candid with the firm you pick. Partnership is a choice leaders keep making long after the contract is signed.
New research, coaching practice, and launch capability thinking for life sciences commercial leaders. About once a month.
We use your email to send articles. Unsubscribe any time.